Member Info for Chelsea11

At the heart of it, is focus on ethnic minorities and underserved communities. Also perhaps some bias towards bowel cancer.

https://questions-statements.parliament.uk/written-statements/detail/2026-01-26/hcws1271

I did previously say I would unfilter you once the SP reached 57p, to see what you had to say.

So you seriously think that now the average cost I paid for all my OMG shares is 57p, I haven’t broken even at that point and that any further gain in the SP doesn’t move me into profit, rather than sitting on a loss here for potentially months? You really believe that?

But shoot it in the right direction……

“So many potential dilution free options for our board to contemplate”

Deffo.

And what a phenomenal problem to have………

Perhaps a whole fleet of limos this year……..

As always, time will tell eh!

Hi Chester - those timelines are quite possible.

Equally however they may prove pessimistic. Genmab have been licensed since Oct 22 on the first product so that is well over 3 years ago already. I do understand typical timelines and also that it’s not just Scancell Genmab are working with but the reality is, we just don’t know at what stage the development has reached. It could be much closer and if a milestone was say £10M quid before the Summer, well that’s not to be sniffed at.

Guess I’m more hopeful that yourself on this point and the would EXPECT used by the Company gives me greater confidence that a cheque will be in the post in the short term.

Cheers.

Bob on with your prediction Roses.

Crusty is getting very vocal. Perhaps down to having his pants pulled down.

Moving on for the benefit of others, so crack on last word merchant.

Crusty 08:30 - “The commercialisation wheels for Glymab A/S are not beginning to turn”

And you didn’t say that?

Wonder if Crusty still believes that the wheels of commercialisation are not yet starting to turn.

Not sure he just joined this morning.

Probably at least 20 times previously.

Well that didn’t take long did it. After averaging down here (and transparently posting my Buys before the trades were updated here), at current 57p I’m now breaking even on this share and should it rise further, every penny on the SP from here is profit.

I was told by Trumpsky that (quotes), “a fool and his money are easily parted” and that it was a “stupid strategy”. What sage investment advice that was from someone who remains so far underwater here he won’t even disclose his average!

Well done again to all those who could see this had been oversold and bought in or topped up / averaged down around the 40p mark. Undisputable facts but then again……….😂

Crusty - how can you claim to know the status of the products in the pipeline.

You don’t. Simple as that.

🙄

Crusty - super negative viewpoint.

Commercialisation wheels at the Company are beginning to turn. That is the point.

Scancell also has two active revenue-generating collaborations with Genmab A/S for other candidates under which it EXPECTS to receive further milestone payments.

EXPECTS!

I think also, some folk might be waiting to hear what is said following the Interims RNS, which we know is landing on Thurs.

Https://www.proactiveinvestors.co.uk/companies/news/1086219/scancell-cleared-by-fda-for-phase-3-trial-1086219.html

I’ve said it before. RF Kennedy talks more bobbins than the orange one.

Imagine that!

As predicted yesterday 😉